Survivorship, version 1.2021 featured updates to the NCCN guidelines

Amye Tevaarwerk; Crystal S. Denlinger; Tara Sanft; Shannon M. Ansbaugh; Saro Armenian; K. Scott Baker; Gregory Broderick; Andrew Day; Wendy Demark-Wahnefried; Kristin Dickinson; Debra L. Friedman; Patricia Ganz; Mindy Goldman; Norah Lynn Henry; Christine Hill-Kayser; Melissa Hudson; Nazanin Khakpour; Divya Koura; Allison L. McDonough; Michelle Melisko; Kathi Mooney; Halle C.F. Moore; Natalie Moryl; Javid J. Moslehi; Tracey O'Connor; Linda Overholser; Electra D. Paskett; Chirayu Patel; Lindsay Peterson; William Pirl; M. Alma Rodriguez; Kathryn J. Ruddy; Lidia Schapira; Lillie Shockney; Sophia Smith; Karen L. Syrjala; Phyllis Zee; Nicole R. McMillian; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2021.0028

Survivorship, version 1.2021 featured updates to the NCCN guidelines

Amye Tevaarwerk, Crystal S. Denlinger, Tara Sanft, Shannon M. Ansbaugh, Saro Armenian, K. Scott Baker, Gregory Broderick, Andrew Day, Wendy Demark-Wahnefried, Kristin Dickinson, Debra L. Friedman, Patricia Ganz, Mindy Goldman, Norah Lynn Henry, Christine Hill-Kayser, Melissa Hudson, Nazanin Khakpour, Divya Koura, Allison L. McDonough, Michelle MeliskoKathi Mooney, Halle C.F. Moore, Natalie Moryl, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Chirayu Patel, Lindsay Peterson, William Pirl, M. Alma Rodriguez, Kathryn J. Ruddy, Lidia Schapira, Lillie Shockney, Sophia Smith, Karen L. Syrjala, Phyllis Zee, Nicole R. McMillian, Deborah A. Freedman-Cass

Medical Oncology

Research output: Contribution to journal › Review article › peer-review

Abstract

The NCCN Guidelines for Survivorship are intended to help healthcare professionals working with cancer survivors to ensure that each survivor's complex and varied needs are addressed. The Guidelines provide screening, evaluation, and treatment recommendations for consequences of adult-onset cancer and its treatment; recommendations to help promote healthful lifestyle behaviors, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes the recommendations regarding employment and return to work for cancer survivors that were added in the 2021 version of the NCCN Guidelines.

Original language	English (US)
Pages (from-to)	676-685
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	19
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2021.0028
State	Published - Jun 2021

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2021.0028

Cite this

Tevaarwerk, A., Denlinger, C. S., Sanft, T., Ansbaugh, S. M., Armenian, S., Scott Baker, K., Broderick, G., Day, A., Demark-Wahnefried, W., Dickinson, K., Friedman, D. L., Ganz, P., Goldman, M., Henry, N. L., Hill-Kayser, C., Hudson, M., Khakpour, N., Koura, D., McDonough, A. L., ... Freedman-Cass, D. A. (2021). Survivorship, version 1.2021 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 19(6), 676-685. https://doi.org/10.6004/jnccn.2021.0028

Tevaarwerk, A, Denlinger, CS, Sanft, T, Ansbaugh, SM, Armenian, S, Scott Baker, K, Broderick, G, Day, A, Demark-Wahnefried, W, Dickinson, K, Friedman, DL, Ganz, P, Goldman, M, Henry, NL, Hill-Kayser, C, Hudson, M, Khakpour, N, Koura, D, McDonough, AL, Melisko, M, Mooney, K, Moore, HCF, Moryl, N, Moslehi, JJ, O'Connor, T, Overholser, L, Paskett, ED, Patel, C, Peterson, L, Pirl, W, Rodriguez, MA, Ruddy, KJ, Schapira, L, Shockney, L, Smith, S, Syrjala, KL, Zee, P, McMillian, NR & Freedman-Cass, DA 2021, 'Survivorship, version 1.2021 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 19, no. 6, pp. 676-685. https://doi.org/10.6004/jnccn.2021.0028

@article{7a3463ce1dcb498a9eb1eeaae042be85,

title = "Survivorship, version 1.2021 featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Survivorship are intended to help healthcare professionals working with cancer survivors to ensure that each survivor's complex and varied needs are addressed. The Guidelines provide screening, evaluation, and treatment recommendations for consequences of adult-onset cancer and its treatment; recommendations to help promote healthful lifestyle behaviors, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes the recommendations regarding employment and return to work for cancer survivors that were added in the 2021 version of the NCCN Guidelines.",

author = "Amye Tevaarwerk and Denlinger, {Crystal S.} and Tara Sanft and Ansbaugh, {Shannon M.} and Saro Armenian and {Scott Baker}, K. and Gregory Broderick and Andrew Day and Wendy Demark-Wahnefried and Kristin Dickinson and Friedman, {Debra L.} and Patricia Ganz and Mindy Goldman and Henry, {Norah Lynn} and Christine Hill-Kayser and Melissa Hudson and Nazanin Khakpour and Divya Koura and McDonough, {Allison L.} and Michelle Melisko and Kathi Mooney and Moore, {Halle C.F.} and Natalie Moryl and Moslehi, {Javid J.} and Tracey O'Connor and Linda Overholser and Paskett, {Electra D.} and Chirayu Patel and Lindsay Peterson and William Pirl and Rodriguez, {M. Alma} and Ruddy, {Kathryn J.} and Lidia Schapira and Lillie Shockney and Sophia Smith and Syrjala, {Karen L.} and Phyllis Zee and McMillian, {Nicole R.} and Freedman-Cass, {Deborah A.}",

note = "Funding Information: This activity is supported by educational grants from Agios Pharmaceuticals; AstraZeneca; Clovis Oncology, Inc.; Daiichi Sankyo; Eisai; Epizyme Inc.; Novartis; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. This activity is supported by an independent medical education grant from Bristol-Myers Squibb, and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical educational grant from Mylan Inc. This activity is supported by a medical education grant from Karyopharm Therapeutics. This activity is supported by an independent educational grant from AbbVie. Publisher Copyright: {\textcopyright} 2021 Harborside Press. All rights reserved.",

year = "2021",

month = jun,

doi = "10.6004/jnccn.2021.0028",

language = "English (US)",

volume = "19",

pages = "676--685",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "6",

}

TY - JOUR

T1 - Survivorship, version 1.2021 featured updates to the NCCN guidelines

AU - Tevaarwerk, Amye

AU - Denlinger, Crystal S.

AU - Sanft, Tara

AU - Ansbaugh, Shannon M.

AU - Armenian, Saro

AU - Scott Baker, K.

AU - Broderick, Gregory

AU - Day, Andrew

AU - Demark-Wahnefried, Wendy

AU - Dickinson, Kristin

AU - Friedman, Debra L.

AU - Ganz, Patricia

AU - Goldman, Mindy

AU - Henry, Norah Lynn

AU - Hill-Kayser, Christine

AU - Hudson, Melissa

AU - Khakpour, Nazanin

AU - Koura, Divya

AU - McDonough, Allison L.

AU - Melisko, Michelle

AU - Mooney, Kathi

AU - Moore, Halle C.F.

AU - Moryl, Natalie

AU - Moslehi, Javid J.

AU - O'Connor, Tracey

AU - Overholser, Linda

AU - Paskett, Electra D.

AU - Patel, Chirayu

AU - Peterson, Lindsay

AU - Pirl, William

AU - Rodriguez, M. Alma

AU - Ruddy, Kathryn J.

AU - Schapira, Lidia

AU - Shockney, Lillie

AU - Smith, Sophia

AU - Syrjala, Karen L.

AU - Zee, Phyllis

AU - McMillian, Nicole R.

AU - Freedman-Cass, Deborah A.

N1 - Funding Information: This activity is supported by educational grants from Agios Pharmaceuticals; AstraZeneca; Clovis Oncology, Inc.; Daiichi Sankyo; Eisai; Epizyme Inc.; Novartis; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. This activity is supported by an independent medical education grant from Bristol-Myers Squibb, and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical educational grant from Mylan Inc. This activity is supported by a medical education grant from Karyopharm Therapeutics. This activity is supported by an independent educational grant from AbbVie. Publisher Copyright: © 2021 Harborside Press. All rights reserved.

PY - 2021/6

Y1 - 2021/6

N2 - The NCCN Guidelines for Survivorship are intended to help healthcare professionals working with cancer survivors to ensure that each survivor's complex and varied needs are addressed. The Guidelines provide screening, evaluation, and treatment recommendations for consequences of adult-onset cancer and its treatment; recommendations to help promote healthful lifestyle behaviors, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes the recommendations regarding employment and return to work for cancer survivors that were added in the 2021 version of the NCCN Guidelines.

AB - The NCCN Guidelines for Survivorship are intended to help healthcare professionals working with cancer survivors to ensure that each survivor's complex and varied needs are addressed. The Guidelines provide screening, evaluation, and treatment recommendations for consequences of adult-onset cancer and its treatment; recommendations to help promote healthful lifestyle behaviors, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes the recommendations regarding employment and return to work for cancer survivors that were added in the 2021 version of the NCCN Guidelines.

UR - http://www.scopus.com/inward/record.url?scp=85110351484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110351484&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2021.0028

DO - 10.6004/jnccn.2021.0028

M3 - Review article

C2 - 34214969

AN - SCOPUS:85110351484

SN - 1540-1405

VL - 19

SP - 676

EP - 685

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Survivorship, version 1.2021 featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this